Pharmacy Department of Xiangtan Central Hospital, Xiangtan, Hunan 411100, China.
Pharmacy Department of Xiangtan Central Hospital, Xiangtan, Hunan 411100, China.
J Ethnopharmacol. 2020 Jan 30;247:112275. doi: 10.1016/j.jep.2019.112275. Epub 2019 Oct 4.
Diabetic retinopathy (DR) is a terrible microvascular disorder causing blindness. Retinal inflammation is the early stage in DR, which is believed to play a crucial role in the development of it. Shengpuhuang-tang (ST), a traditional herbal formula, which has effective treatment of fundus bleeding disorder. ST exerts protective effects against DR in rats, but its underlying mechanism of this efficacy remains unknown. Thus, the objective of this study is to examine the mechanism and the efficacy of ST on retinal inflammation in streptozotocin-induced diabetic rats.
The administration of ST was initiated at 4 weeks after diabetes induction and continued for 12 weeks. Retinal vessel permeability was evaluated by using FITC-dextran and Evans blue. Retinal leukostasis was evaluated with FITC-coupled concanavalin A lectin (ConA). Moreover, western blotting was performed to detect TNF-α, ICAM-1 and the relative expression levels of IκBα, IKKβ, and p65 in vivo.
The results showed that the retinal inflammation in streptozotocin-induced diabetic rats was significantly decreased by ST. ST could decreased the expression levels of TNF-α, ICAM-1 and inhibited the expression of p-IKKβ, p-p65 and IκBα. It could also inhibited the nuclear transfer of p65.
In conclusion, these data suggested that ST may have potential treatment strategies against early stage of diabetic retinopathy through NF-κB pathway.
糖尿病性视网膜病变(DR)是一种严重的微血管疾病,可导致失明。视网膜炎症是 DR 的早期阶段,被认为在其发展中起着关键作用。圣朴黄汤(ST)是一种传统的草药配方,对眼底出血性疾病有有效治疗作用。ST 对糖尿病大鼠的 DR 具有保护作用,但其疗效的潜在机制尚不清楚。因此,本研究旨在探讨 ST 对链脲佐菌素诱导的糖尿病大鼠视网膜炎症的作用机制和疗效。
糖尿病诱导后 4 周开始给予 ST 治疗,并持续 12 周。通过 FITC-葡聚糖和 Evans 蓝评估视网膜血管通透性。通过 FITC 结合刀豆球蛋白 A 凝集素(ConA)评估视网膜白细胞淤滞。此外,还进行了 Western blot 以检测体内 TNF-α、ICAM-1 以及 IκBα、IKKβ 和 p65 的相对表达水平。
结果表明,ST 可显著减轻链脲佐菌素诱导的糖尿病大鼠的视网膜炎症。ST 可降低 TNF-α、ICAM-1 的表达水平,并抑制 p-IKKβ、p-p65 和 IκBα的表达。它还可以抑制 p65 的核转位。
综上所述,这些数据表明 ST 可能通过 NF-κB 途径为治疗糖尿病性视网膜病变的早期阶段提供了潜在的治疗策略。